COVID-19 Research at Sutter

Our researchers are at the forefront of advancing science on COVID-19. We're working with leading experts from public and private organizations across the country. Our goal is to help find innovative ways to detect, treat and prevent the spread of coronavirus to help safeguard your health.

Enroll in Clinical Trials

COVID-19 Research and Clinical Trials

We’re contributing to solutions to help end the pandemic.

COVID-19 Treatments

Sutter researchers are studying new therapies in clinical trials:

Seven Sutter acute care centers enrolled patients to clinical trials of remdesivir.
We collaborated on a treatment using convalescent plasma.
Our teams are testing monoclonal antibodies against COVID-19.

COVID-19 Prevention

Alta Bates Summit Medical Center is studying COVID-19 vaccines by:

Testing the safety and effectiveness of a vaccine made by AstraZeneca.
Working with other leading healthcare organizations in the Bay Area.

Mental Health

We're studying the impact of COVID-19 on mental health by:

Exploring new ways to prevent anxiety and depression in youth.
Identifying clues for early detection of mental health concerns.

Predicting COVID-19

Our researchers are searching for biomarkers that can help identify high-risk patients hospitalized for COVID-19.

Forecasting Spread

Sutter has created data registries to compile statistical information to help predict the spread of COVID-19.

At Sutter, we’re dedicated to advancing equitable health outcomes for our communities. Our Health Equity team continues to study our COVID-19 patients to learn how this disease affects people based on race and ethnicity by:

Partnering with UCSF and other healthcare sites to determine how different factors affect access to COVID-19 testing and treatment.
Launching Sutter’s Maternal CARE Study, which aims to increase understanding of whether and how COVID-19 exposure during pregnancy differs by race and ethnicity.

Advancing Health Equity

Sutter Health Research